Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Q3 2022 Earnings Conference Call November 10, 2022 8:30 AM ET Company Participants Mike Beaulieu - Investor Relations Rob Spignesi - Chief Executive Officer Sean Wirtjes - Chief Financial Officer Conference Call Participants Dan Arias - Stifel Rachel Vatnsdal - JPMorgan Stephanie Yan - Cowen Operator Hello. My name is Lisa and I will be your conference operator today. At this time, I would like to welcome everyone to the Rapid Micro Biosystems Third Quarter 2022 Ea ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________________________________ FORM 10-Q ________________________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________________ to ________________ Commission File N ...

Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Q2 2022 Earnings Conference Call August 12, 2022 8:30 AM ET Company Participants Mike Beaulieu - CFA Vice President, Investor Relations & Corporate Communications Rob Spignesi - Chief Executive Officer Sean Wirtjes - Chief Financial Officer Conference Call Participants Yuko Oku - Morgan Stanley Dan Arias - Stifel Stephanie Yan - Cowen Rachel Cascio - JPMorgan Operator Ladies and gentlemen, thank you for standing by and welcome to the Rapid Micro Biosystems Second Q ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40592 Rapid Micro Biosystems, Inc. (Exact name of registrant as specified in its charter) Delaware 20-8121647 ...

Rapid Micro Biosystems Inc. (NASDAQ:RPID) Q1 2022 Earnings Conference Call May 10, 2022 8:30 AM ET Company Participants Michael Beaulieu - CFA Vice President, Investor Relations and Corporate Communications Robert Spignesi - President and Chief Executive Officer Sean Wirtjes - Chief Financial Officer Conference Call Participants Yuko Oku - Morgan Stanley Noah Burhance - JPMorgan Operator Good day, and thank you for standing by. Welcome to the Rapid Micro Biosystems First Quarter 2022 Earnings Conference Ca ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40592 Rapid Micro Biosystems, Inc. (Exact name of registrant as specified in its charter) Delaware 20-8121647 ...

TABLE OF CONTENTS | | | Page | | --- | --- | --- | | PART I | | | | Item 1. | Business | 7 | | Item 1A.Risk Factors | | 37 | | Item 1B. Unresolved Staff Comments | | 76 | | Item 2. | Properties | 76 | | Item 3. | Legal Proceedings | 76 | | Item 4. | Mine Safety Disclosures | 76 | | PART II | | | | Item 5. | Market for Registrant's Common Equity, Related Stockholder Matters and Issuer | | | Purchases of Equity Securities | | 78 | | Item 6. | Reserved | 78 | | Management's Discussion and Analysis of Financial ...

Rapid Micro Biosystems MARCH 2022 This presentation has been prepared by Rapid Micro Biosystems, Inc. (the "Company") solely for informational purposes. This presentation contains forward-looking statements. All statements contained in this presentation that do not relate to matters of historical fact should be considered forward-looking statements, including, but not limited to, statements relating to the our full year 2022 commercial revenue outlook range and expected future revenue and growth; accelerati ...

Rapid Micro Biosystems MARCH 2022 This presentation has been prepared by Rapid Micro Biosystems, Inc. (the "Company") solely for informational purposes. This presentation contains forward-looking statements. All statements contained in this presentation that do not relate to matters of historical fact should be considered forward-looking statements, including, but not limited to, statements relating to the our full year 2022 commercial revenue outlook range and expected future revenue and growth; accelerati ...

Rapid Micro Biosystems Inc. (NASDAQ:RPID) Q4 2021 Earnings Conference Call March 4, 2022 8:30 AM ET Company Participants Mike Beaulieu - CFA Vice President, Investor Relations and Corporate Communications Rob Spignesi - President and Chief Executive Officer Sean Wirtjes - Chief Financial Officer Conference Call Participants Max Masucci - Cowen Casey Woodring - JPMorgan Dan Arias - Stifel Tejas Savant - Morgan Stanley Disclaimer*: This transcript is designed to be used alongside the freely available audio re ...